Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan

International Journal of Antimicrobial Agents

Volumn 41, Issue 3, 2013, Pages 218-223

  Huang, Chien Wen ^a   Chen, Jiann Hwa ^b   Hu, Shiau Ting ^c   Huang, Wei Chang ^d   Lee, Yen Chung ^e   Huang, Chen Cheng ^f   Shen, Gwan Han ^d,g,h  

^a FENG YUAN HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^f Taichung Hospital   (Taiwan)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

^h HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Amikacin; Clarithromycin; Mycobacterium abscessus sensu stricto; Mycobacterium bolletii; Mycobacterium massiliense; Rapidly growing mycobacteria; Tigecycline

Indexed keywords

AMIKACIN; CLARITHROMYCIN; DOXYCYCLINE; MINOCYCLINE; TETRACYCLINE; TIGECYCLINE;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; DRUG ANTAGONISM; DRUG POTENTIATION; IN VITRO STUDY; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM BOLLETII; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM MASSILIENSE; NONHUMAN; PRIORITY JOURNAL; TAIWAN;

AMIKACIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG SYNERGISM; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; TAIWAN;

EID: 84872938177     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.10.021     Document Type: Article

References (29)

1. C.C. Lai, C.K. Tan, C.H. Chou, H.L. Hsu, C.H. Liao, and Y.T. Huang Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008 Emerg Infect Dis 16 2010 294 296
2. H. Medjahed, J.L. Gaillard, and J.M. Reyrat Mycobacterium abscessus: a new player in the mycobacterial field Trends Microbiol 18 2010 117 123
3. D.E. Griffith, T. Aksamit, B.A. Brown-Elliott, A. Catanzaro, C. Daley, and F. Gordin An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases Am J Respir Crit Care Med 175 2007 367 416 Erratum in: Am J Respir Crit Care Med 2007;175:744-5
4. R. Nessar, E. Cambau, J.M. Reyrat, A. Murray, and B. Gicquel Mycobacterium abscessus: a new antibiotic nightmare J Antimicrob Chemother 67 2012 810 818
5. J. Jarand, A. Levin, L. Zhang, G. Huitt, J.D. Mitchell, and C.L. Daley Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease Clin Infect Dis 52 2011 565 571
6. W.J. Koh, O.J. Kwon, and K.S. Lee Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective J Korean Med Sci 20 2005 913 925 (Pubitemid 43161852)
7. K. Jeon, O.J. Kwon, N.Y. Lee, B.J. Kim, Y.H. Kook, and S.H. Lee Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients Am J Respir Crit Care Med 180 2009 896 902
8. S. Regnier, E. Cambau, J.P. Meningaud, A. Guihot, L. Deforges, and A. Carbonne Clinical management of rapidly growing mycobacterial cutaneous infections in patients after mesotherapy Clin Infect Dis 49 2009 1358 1364
9. R.J. Wallace Jr., B.A. Brown-Elliott, C.J. Crist, L. Mann, and R.W. Wilson Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria Antimicrob Agents Chemother 46 2002 3164 3167
10. J. Esteban, N.Z. Martín-de-Hijas, A. Ortiz, T.J. Kinnari, A. Bodas Sánchez, and I. Gadea Detection of lfrA and tap efflux pump genes among clinical isolates of non-pigmented rapidly growing mycobacteria Int J Antimicrob Agents 34 2009 454 456
11. D. Yahav, A. Lador, M. Paul, and L. Leibovici Efficacy and safety of tigecycline: a systematic review and meta-analysis J Antimicrob Chemother 66 2011 1963 1971
12. S.C. Yang, P.R. Hsueh, H.C. Lai, L.J. Teng, L.M. Huang, and J.M. Chen High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan Antimicrob Agents Chemother 47 2003 1958 1962
13. T.S. Huang, S.S. Lee, P.R. Tsai, Y.S. Chen, S.R. Wann, and H.S. Leu Antimicrobial resistance of rapidly growing mycobacteria in western Taiwan: SMART program 2002 J Formos Med Assoc 107 2008 281 287 (Pubitemid 351663104)
14. A. Telenti, F. Marchesi, M. Balz, F. Bally, E.C. Bottger, and T. Bodmer Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis J Clin Microbiol 31 1993 175 178 (Pubitemid 23028605)
15. G.E. Choi, C.L. Chang, J. Whang, H.J. Kim, O.J. Kwon, and W.J. Koh Efficient differentiation of Mycobacterium abscessus complex isolates to the species level by a novel PCR-based variable-number tandem-repeat assay J Clin Microbiol 49 2011 1107 1109
16. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. 2nd ed. Document M24-A2. Wayne, PA: CLSI; 2011.
17. S. Bastian, N. Veziris, A.L. Roux, F. Brossier, J.L. Gaillard, and V. Jarlier Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing Antimicrob Agents Chemother 55 2011 775 781
18. K.A. Nash, B.A. Brown-Elliott, and R.J. Wallace Jr. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae Antimicrob Agents Chemother 53 2009 1367 1376
19. G.H. Shen, B.D. Wu, S.T. Hu, C.F. Lin, K.M. Wu, and J.H. Chen High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria Int J Antimicrob Agents 35 2010 400 404
20. A. De Logu, V. Onnis, B. Saddi, C. Congiu, M.L. Schivo, and M.T. Cocco Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis J Antimicrob Chemother 49 2002 275 282 (Pubitemid 34162617)
21. F.C. Odds Synergy, antagonism, and what the chequerboard puts between them J Antimicrob Chemother 52 2003 1 (Pubitemid 36850074)
22. Y.C. Huang, M.F. Liu, G.H. Shen, C.F. Lin, C.C. Kao, and P.Y. Liu Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing J Microbiol Immunol Infect 43 2010 401 406
23. J. Lyu, H.J. Jang, J.W. Song, C.M. Choi, Y.M. Oh, and S.D. Lee Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs Respir Med 105 2011 781 787
24. V. Seputiene, J. Povilonis, J. Armalyte, K. Suziedelis, A. Pavilonis, and E. Suziedeliene Tigecycline - how powerful is it in the fight against antibiotic-resistant bacteria? Medicina (Kaunas) 46 2010 240 248
25. M.L. Townsend, M.W. Pound, and R.H. Drew Tigecycline: a new glycylcycline antimicrobial Int J Clin Pract 60 2006 1662 1672 (Pubitemid 44742168)
26. J. Hylands Tigecycline: a new antibiotic Intensive Crit Care Nurs 24 2008 260 263
27. K. Al-Benwan, S. Ahmad, E. Mokaddas, M. Johny, and M.M. Kapoor Diagnosis of endocarditis caused by Mycobacterium abscessus Ann Saudi Med 30 2010 408 411
28. A.P. Garrison, M.I. Morris, S. Doblecki Lewis, L. Smith, T.J. Cleary, and G.W. Procop Mycobacterium abscessus infection in solid organ transplant recipients: report of three cases and review of the literature Transpl Infect Dis 11 2009 541 548
29. T. Miyasaka, H. Kunishima, M. Komatsu, K. Tamai, K. Mitsutake, and K. Kanemitsu In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus Int J Antimicrob Agents 30 2007 255 258 (Pubitemid 47126819)